Game Plan Financial Advisors, LLC Oragenics Inc Transaction History

Game Plan Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$0.52 - $1.52 $5,200 - $15,200	-10,000 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$0.39 - $0.6 $3,900 - $6,000	10,000 New	10,000 $5,000
Q3 2020 Nov 09, 2020	SELL	$0.56 - $1.49 $5,600 - $14,900	-10,000 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$0.39 - $0.83 $3,900 - $8,300	10,000 New	10,000 $7,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.